urigan

urigan


Urigan for Cystitis Management
Urigan features an extract derived from birch leaves and lovage root, which are known for their diuretic and anti-inflammatory properties, especially in cases of urinary tract infections. This remedy is typically taken at a dosage of 50 drops three times daily, mixed in water. Its primary function involves enhancing urine production to help mechanically eliminate bacteria from the bladder.
The active components in Urigan effectively hinder the adhesion of Escherichia coli to the urinary tract epithelium, as demonstrated by microbiological studies. Flavonoids and essential oils provide antibacterial effects, while saponins contribute to the relaxation of smooth muscles, alleviating pain linked to inflammation.
Generally, Urigan treatment spans a period of 2 to 4 weeks, depending on symptom severity. Many patients notice a decrease in dysuria and overall urination frequency within just 3 to 5 days of consistent intake. The remedy can also be taken alongside antibiotics, amplifying the therapeutic benefits and reducing the overall treatment duration by approximately 30%.
In clinical trials involving 240 women with recurring infections, a preventive regimen of Urigan over six months led to a 56% decrease in inflammation incidents. The preparation is well-tolerated, with side effects affecting fewer than 2% of users, primarily causing mild digestive discomfort.
Contraindications for Urigan include allergic reactions to its components, heart or kidney failure, dehydration, and edema linked to circulatory issues. Pregnant women are advised to seek medical advice prior to usage, as safety data during pregnancy is limited.
Urigan's Mechanism of Action Against Cystitis-Causing Bacteria
Urigan incorporates cranberry extract, which contains proanthocyanidins type A (PAC-A) at a concentration of no less than 36 mg per capsule. These compounds inhibit the binding of Escherichia coli bacteria to the urinary tract epithelium by altering the structure of bacterial fimbriae, thus preventing the pathogens from adhering to host cells. This anti-adhesive action particularly impacts uropathogenic strains of E. coli equipped with P and type 1 fimbriae, responsible for 80-90% of lower urinary tract infections.
The presence of proanthocyanidins modifies the physicochemical characteristics of the bacterial surface, neutralizing electric charges that facilitate adhesion to cellular receptors. As a result, bacteria that lose their ability to adhere are excreted with urine rather than colonizing the bladder. The active compounds remain in the urine for 8 to 12 hours after ingestion, ensuring prolonged protection against reinfection.
Additionally, the formulation exhibits anti-inflammatory effects by diminishing the production of the inflammatory cytokines IL-6 and IL-8 in bladder epithelial cells. Clinical investigations indicate that regular intake of cranberry extract at a daily dose of 72 mg PAC-A leads to a 40-50% reduction in cystitis recurrence among women suffering from chronic infections. Other components of Urigan, including vitamin C, lower the urine pH to 5.5-6.0, creating an inhospitable environment for the growth of anaerobic bacteria and uropathogenic strains of Proteus mirabilis.
Recommended Dosage and Administration of Urigan for Urinary Tract Infections
The recommended dosage of Urigan for cystitis treatment is 1-2 capsules two times daily, ideally taken in the morning and evening with a substantial amount of water (at least 200 ml). It is advised to take the preparation before or during meals to reduce the risk of gastrointestinal upset. The treatment duration typically ranges from 7 to 10 days for acute infections, with an option to extend to 14-21 days for recurrent cases. The manufacturer advises against exceeding a maximum daily limit of 4 capsules unless a healthcare provider suggests otherwise based on the individual’s condition.
While using Urigan, it is crucial to increase water consumption to 2-2.5 liters daily, facilitating the elimination of bacteria from the urinary tract. Patients should consistently take the remedy at the same times, ensuring even intervals between doses. If a dose is missed, it's important not to double the next dose but to continue according to the prescribed regimen. Should there be no improvement in symptoms after 3-4 days of treatment, or if symptoms such as fever, hematuria, or heightened lumbar pain arise, the patient must consult a healthcare professional immediately. This preparation may be combined with antibiotics as prescribed by a healthcare specialist, ensuring a two-hour gap between the two medications.